Research ArticleNuclear Oncology
Staging Recurrent Metastatic Colorectal Carcinoma with Pet
Dominique Delbeke, João V. Vitola, Martin P. Sandler, Ronald C. Arildsen, Thomas A. Powers, J. Kelly Wright, William C. Chapman and C. Wright Pinson
Journal of Nuclear Medicine August 1997, 38 (8) 1196-1201;
Dominique Delbeke
João V. Vitola
Martin P. Sandler
Ronald C. Arildsen
Thomas A. Powers
J. Kelly Wright Jr.
William C. Chapman
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Staging Recurrent Metastatic Colorectal Carcinoma with Pet
Dominique Delbeke, João V. Vitola, Martin P. Sandler, Ronald C. Arildsen, Thomas A. Powers, J. Kelly Wright, William C. Chapman, C. Wright Pinson
Journal of Nuclear Medicine Aug 1997, 38 (8) 1196-1201;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Positron Emission Tomography-Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial
- Value of Retrospective Fusion of PET and MR Images in Detection of Hepatic Metastases: Comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-Enhanced MRI
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- 18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22 The NCRI Testis Tumour Clinical Study Group
- Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer
- Use of a Decision Analysis Model to Assess the Cost-Effectiveness of 18F-FDG PET in the Management of Metachronous Liver Metastases of Colorectal Cancer
- Comparison Between 18F-FDG PET, In-Line PET/CT, and Software Fusion for Restaging of Recurrent Colorectal Cancer
- Metabolic Response After Intraarterial 90Y-Glass Microsphere Treatment for Colorectal Liver Metastases: Comparison of Quantitative and Visual Analyses by 18F-FDG PET
- In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography
- Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma
- 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
- Efficacy of Fluorine-18-Deoxyglucose Positron Emission Tomography in Detecting Tumor Recurrence After Local Ablative Therapy for Liver Metastases: A Prospective Study
- Role of 18F-FDG Dual-Head Gamma-Camera Coincidence Imaging in Recurrent or Metastatic Colorectal Carcinoma
- Whole body applications of positron emission tomography in oncology
- 18F-FDG PET Detection of Colonic Adenomas
- A Tabulated Summary of the FDG PET Literature
- Impact of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography on Patient Management: First Year's Experience in a Clinical Center
- Impact of 18F-FDG PET on Managing Patients with Colorectal Cancer: The Referring Physician's Perspective
- The Diagnostic Utility of the Lognormal Behavior of PET Standardized Uptake Values in Tumors
- FDG PET and Immunoscintigraphy with 99mTc-Labeled Antibody Fragments for Detection of the Recurrence of Colorectal Carcinoma
- Additional Value of Whole-Body Positron Emission Tomography With Fluorine-18-2-Fluoro-2-deoxy-D-glucose in Recurrent Colorectal Cancer